Company Profile of Suzhou Oubinuo Biotechnology Co., Ltd.

Suzhou Oubinuo Biotechnology Co., Ltd. Was founded in May 2024 with a registered and paid-in capital of 10 million RMB. Located at Zhangjiagang, Suzhou, Jiangsu Province, the company is a high-tech enterprise focusing on acoustic tweezers technology R&D, life science instrument manufacturing and industrial application. As a wholly-owned subsidiary of Wuhan Oubinuo Biotechnology Co., Ltd., it relies on years of technical accumulation to promote domestic substitution of high-end life science instruments, integrating R&D, production, sales and technical services into a complete system.

Since 2021, the team has completed core technological breakthroughs in acoustic field control, microfluidic systems and key algorithms. After its establishment in 2024, the company quickly built a complete R&D and pilot production base. In 2025, its core project won the First Prize in the Biomedical and High-end Medical Devices Category of Jiangsu Talent Innovation and Entrepreneurship Competition. The company has realized small-batch production and obtained orders from universities, pharmaceutical enterprises and research institutions.

The company's flagship product, the Soundpen CB single-cell sorting system, features non-contact, label-free and high-viability cell processing, with performance comparable to international brands and obvious cost advantages. Up to now, the company has applied for 17 invention patents covering single-cell manipulation, droplet generation and nanoparticle sorting, forming a solid technical barrier. Its products are widely used in single-cell sequencing, antibody drug development, cell line construction, organoid culture, exosome separation and other fields.

The business scope includes technology development, service and promotion; R&D, production and sales of Class I, II and III medical devices; Manufacturing of experimental analytical instruments; Assembly of electronic components; R&D and application of cell technology. Based on acoustic tweezers technology, the company provides standardized equipment and customized solutions for life science research, innovative drug R&D, cell therapy, tissue engineering and precision medicine.

Benefiting from national policies supporting domestic substitution and rapid development of the biopharmaceutical industry, acoustic tweezers technology has broad prospects. The company will continue to increase R&D investment, upgrade product performance, expand automated and integrated equipment lines, and improve production capacity and service capabilities. It will strengthen industry-university-research cooperation and accelerate medical device registration.

In the future, Suzhou Oubinuo is committed to becoming a global leader in acoustic tweezers and life science instruments, providing reliable, efficient and cost-effective domestic equipment for life science research and biopharmaceutical industry, and promoting industrial innovation and high-quality development.